Search Results for 'Infliximab'

Infliximab published presentations and documents on DocSlides.

INFLIXIMAB/HACA MEASUREMENT

INFLIXIMAB/HACA MEASUREMENT

by dudeja

Lab Dept: Chemistry Test Name: General Information...

Infliximab (DB00065) Approved Drug

Infliximab (DB00065) Approved Drug

by madeline

Chemical Formula: C. 6428. H. 9912. N. 1694. O. 19...

When can we use combination therapy for our pediatric IBD p

When can we use combination therapy for our pediatric IBD p

by pasty-toler

Athos Bousvaros MD, MPH. Advances in IBD Dec 2014...

Should we change how we position biologics in

Should we change how we position biologics in

by natalia-silvester

ulcerative colitis?. Bruce E. Sands, MD, MS. Chie...

by lindy-dunigan

with severe . Crohn's. . disease, an . ileal. s...

Colitis in the Very Young

Colitis in the Very Young

by faustina-dinatale

Case. 8 month old presented with bloody bowel mov...

Acceptable changes in quality attributes of glycosylated bi

Acceptable changes in quality attributes of glycosylated bi

by debby-jeon

Schiestl M, Stangler T, Torella C, et al. . Nat B...

Biosimilars in RA: A Blessing or a Curse?

Biosimilars in RA: A Blessing or a Curse?

by conchita-marotz

Introduction/Overview . What Is a Biosimilar?. Di...

Pro: All medications may be stopped for Crohn’s disease p

Pro: All medications may be stopped for Crohn’s disease p

by briana-ranney

Miguel Regueiro, M.D.. Professor of Medicine. Ass...

by olivia-moreira

disease: diagnosis and management. د. حسين ...

Can Rheumatoid Arthritis treatment ever be stopped?

Can Rheumatoid Arthritis treatment ever be stopped?

by celsa-spraggs

Robert L. DiGiovanni, DO, FACOI. Program Director...

Future comparative effectiveness studies:

Future comparative effectiveness studies:

by calandra-battersby

unanswered questions. in the care of IBD patient...

by giovanna-bartolotta

Ewan Hunter PhD . Director Technical Support EMEA...

©2010 MFMER | slide-

©2010 MFMER | slide-

by myesha-ticknor

1. Edward V. Loftus, Jr., M.D.. Professor of Medi...

Should we change how we position biologics for their use in

Should we change how we position biologics for their use in

by tawny-fly

Stephen B. Hanauer, MD. Professor of Medicine,. N...

Prevention of Postoperative Crohn’s disease

Prevention of Postoperative Crohn’s disease

by jane-oiler

Miguel Regueiro, M.D.. Professor of Medicine. Ass...

Biosimilars in the Real World

Biosimilars in the Real World

by liane-varnes

Introduction/Overview . PLANETRA Extension Study:...

Inflammatory Bowel Disease

Inflammatory Bowel Disease

by natalia-silvester

Dr. Omar Mansour. Consultant Colorectal & La...

The generic and biosimilar

The generic and biosimilar

by alida-meadow

perspective. Warwick Smith. Director General BGMA...

Inflammatory Bowel Disease

Inflammatory Bowel Disease

by debby-jeon

Dr. Omar Mansour. Consultant Colorectal & La...

JAPIVOL 52MARCH 2004wwwjapiorg231

JAPIVOL 52MARCH 2004wwwjapiorg231

by stella

Update ArticleBiologics in Rheumatoid ArthritisP K...

Part B Medical Drugs Requiring Step

Part B Medical Drugs Requiring Step

by udeline

-TherapyDrug subject to Step TherapyTry these Opti...

DRUG NAMES AND MEDICATION ERRORS

DRUG NAMES AND MEDICATION ERRORS

by freya

1. DRUG NAMES. Chemical name. Development name use...

PROFILE - Trial Design A randomised, multi-centre, biomarker-stratified open-label trial in patient

by LuckyLadybug

V4.1 25.06.2020. Issue. Clinical course / prognosi...

PsoriaticarthritistreatmentbiologicalresponsemodifiersPJMeaseCEAnton

PsoriaticarthritistreatmentbiologicalresponsemodifiersPJMeaseCEAnton

by eve

Abbreviations:ACR,AmericanCollegeofRheumatology;DM...

What is the value of Real-World Evidence for Biosimilars?

What is the value of Real-World Evidence for Biosimilars?

by bitsy

Disclaimer. This panel is moderated by Dr. Delphin...